Insider Trading activities of Haemonetics Corp insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Haemonetics Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Haemonetics Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Haemonetics Corp since 2005. The reporting company's ticker symbol is HAE. The reporting company's CIK number is 313143.
The total value of stock buying since 2005 is $9,297,802.
The total value of stock sales since 2005 is $165,120,821.
The total value of stock option exercises since 2005 is $80,860,127.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Haemonetics Corp insiders (HAE) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-02-10 Allen Peter M (President, Global Plasma) Sale 2,100 65.57 137,697
2012-02-10 Allen Peter M (President, Global Plasma) Option Ex 2,100 21.46 45,066
2012-02-01 Concannon Brian (President & CEO) Sale 5,000 65.06 325,300
2012-02-01 Concannon Brian (President & CEO) Option Ex 5,000 31.89 159,460
2012-01-06 Allen Peter M (Chief Marketing Officer) Sale 15,000 61.87 928,095
2012-01-06 Allen Peter M (Chief Marketing Officer) Option Ex 15,000 31.30 469,575
2012-01-03 Concannon Brian (President & CEO) Sale 5,000 62.49 312,440
2012-01-03 Concannon Brian (President & CEO) Option Ex 5,000 31.89 159,460
2011-12-01 Concannon Brian (President & CEO) Sale 5,000 58.76 293,800
2011-12-01 Concannon Brian (President & CEO) Option Ex 5,000 31.89 159,460
2011-11-03 Gordon Mikael (President, Haemonetics Europe) Buy 228 51.81 11,811
2011-11-03 Lindop Christopher J (CFO & Vice President of) Buy 217 51.81 11,242
2011-11-03 Allen Peter M (Chief Marketing Officer) Buy 203 51.81 10,516
2011-11-03 Hanlon Susan M (VP Finance) Buy 137 51.81 7,097
2011-11-01 Concannon Brian (President & CEO) Sale 5,000 57.70 288,500
2011-11-01 Concannon Brian (President & CEO) Option Ex 5,000 31.89 159,460
2011-10-17 Concannon Brian (President & CEO) Sale 5,000 59.16 295,785
2011-10-17 Concannon Brian (President & CEO) Option Ex 5,000 31.89 159,460
2011-10-07 Allen Peter M (Chief Marketing Officer) Sale 5,000 59.26 296,295
2011-10-07 Allen Peter M (Chief Marketing Officer) Option Ex 5,000 41.15 205,750
2011-09-12 Allen Peter M (Chief Marketing Officer) Sale 2,100 58.09 121,995
2011-09-12 Allen Peter M (Chief Marketing Officer) Option Ex 2,100 21.46 45,066
2011-08-15 Granadillo Pedro P (Director) Sale 850 59.74 50,779
2011-07-15 Allen Peter M (Chief Marketing Officer) Sale 14,000 68.36 956,970
2011-07-15 Allen Peter M (Chief Marketing Officer) Option Ex 14,000 31.30 438,270
2011-07-05 Concannon Brian (President & CEO) Sale 3,000 66.00 198,000
2011-07-05 Concannon Brian (President & CEO) Option Ex 3,000 41.15 123,450
2011-06-03 Allen Peter M (Chief Marketing Officer) Sale 8,350 66.16 552,436
2011-06-03 Allen Peter M (Chief Marketing Officer) Option Ex 8,350 21.46 179,191
2011-05-16 Gordon Mikael (President, Haemonetics Europe) Sale 457 67.28 30,744
2011-05-09 Merriman Ronald (Director) Sale 10,592 67.10 710,723
2011-05-09 Merriman Ronald (Director) Option Ex 10,592 51.34 543,793
2011-05-05 Foote Susan Bartlett (Director) Sale 6,000 67.67 405,990
2011-05-05 Foote Susan Bartlett (Director) Option Ex 6,000 44.74 268,440
2011-05-04 Brancazio Phillip John (VP, Global Manufacturing) Buy 67 46.80 3,135
2011-05-04 White Jonathan (VP Research and Development) Buy 455 46.80 21,294
2011-05-04 Gordon Mikael (President, Haemonetics Europe) Buy 257 46.80 12,027
2011-05-04 Lindop Christopher J (CFO & Vice President of) Buy 273 46.80 12,776
2011-05-04 Allen Peter M (Chief Marketing Officer) Buy 301 46.80 14,087
2011-05-04 Forish Joseph J (VP, Human Resources) Buy 457 46.80 21,388
2011-05-04 Hanlon Susan M (VP Finance) Buy 148 46.80 6,926
2011-03-30 Hanlon Susan M (VP Finance) Sale 3,000 65.00 195,000
2011-03-30 Hanlon Susan M (VP Finance) Option Ex 3,000 30.39 91,155
2011-02-10 Allen Peter M (Chief Marketing Officer) Sale 1,650 59.43 98,056
2011-02-10 Allen Peter M (Chief Marketing Officer) Option Ex 1,650 21.46 35,409
2011-02-07 Best Lawrence C (Director) Sale 16,695 61.87 1,032,852
2011-02-07 Best Lawrence C (Director) Option Ex 16,695 30.44 508,145
2011-02-04 Best Lawrence C (Director) Sale 15,305 61.06 934,553
2011-02-04 Best Lawrence C (Director) Option Ex 15,305 20.46 313,216
2010-12-23 Gelbman Ronald G (Director) Sale 6,000 64.22 385,349
2010-12-23 Gelbman Ronald G (Director) Option Ex 6,000 32.01 192,060
2010-12-13 Lindop Christopher J (CFO & Vice President of) Sale 9,050 62.26 563,480
2010-12-13 Lindop Christopher J (CFO & Vice President of) Option Ex 9,050 48.09 435,214
2010-12-10 Lindop Christopher J (CFO & Vice President of) Sale 8,782 62.71 550,736
2010-12-10 Lindop Christopher J (CFO & Vice President of) Option Ex 8,782 48.09 422,326
2010-12-06 Hanlon Susan M (VP Finance) Sale 3,500 60.99 213,465
2010-12-06 Hanlon Susan M (VP Finance) Option Ex 3,500 30.39 106,347
2010-12-03 Lopez Alicia R (VP, Corporate Affairs) Sale 96,656 60.91 5,887,123
2010-12-03 Lopez Alicia R (VP, Corporate Affairs) Option Ex 96,656 41.49 4,010,450
2010-11-05 Granadillo Pedro P (Director) Sale 6,000 57.72 346,302
2010-11-04 Brancazio Phillip John (VP, Global Manufacturing) Buy 74 46.34 3,428
2010-11-04 White Jonathan (VP Research and Development) Buy 4 46.34 185
2010-11-04 Gordon Mikael (President, Haemonetics Europe) Buy 200 46.34 9,267
2010-11-04 Lindop Christopher J (CFO & Vice President of) Buy 297 46.34 13,761
2010-11-04 Allen Peter M (Chief Marketing Officer) Buy 328 46.34 15,198
2010-11-04 Merriman Ronald (Director) Sale 7,000 58.11 406,763
2010-11-04 Merriman Ronald (Director) Option Ex 7,000 41.15 288,050
2010-11-04 Ruxin Michael I (VP Global Software Strategies) Buy 215 46.34 9,962
2010-11-04 Forish Joseph J (VP, Human Resources) Buy 40 46.34 1,853
2010-11-04 Lopez Alicia R (VP, Corporate Affairs) Buy 150 46.34 6,950
2010-11-04 Hanlon Susan M (VP Finance) Buy 160 46.34 7,413
2010-09-10 Allen Peter M (Chief Marketing Officer) Sale 1,866 54.83 102,316
2010-05-11 Gelbman Ronald G (Director) Sale 9,000 57.02 513,171
2010-04-30 Brancazio Phillip John (VP, Global Manufacturing) Buy 68 45.70 3,107
2010-04-30 White Jonathan (VP Research and Development) Buy 460 45.70 21,024
2010-04-30 Lindop Christopher J (CFO & Vice President of) Buy 279 45.70 12,751
2010-04-30 Allen Peter M (Chief Marketing Officer) Buy 308 45.70 14,077
2010-04-30 Forish Joseph J (VP, Human Resources) Buy 422 45.70 19,287
2010-04-30 Lopez Alicia R (VP, Corporate Affairs) Buy 318 45.70 14,534
2010-04-30 Hanlon Susan M (VP Finance) Buy 151 45.70 6,901
2010-04-27 Gelbman Ronald G (Director) Option Ex 9,000 22.91 206,154
2010-04-16 Lopez Alicia R (VP, Corporate Affairs) Sale 30,867 60.00 1,852,020
2010-04-16 Lopez Alicia R (VP, Corporate Affairs) Option Ex 10,867 22.91 248,919
2010-04-06 Concannon Brian (President & CEO) Sale 165 56.31 9,291
2010-03-25 Nutter Brad (Chairman of the Board) Sale 26,872 57.00 1,531,730
2010-03-25 Nutter Brad (Chairman of the Board) Option Ex 26,872 41.15 1,105,782
2010-03-24 Nutter Brad (Chairman of the Board) Sale 100 57.00 5,700
2010-03-24 Nutter Brad (Chairman of the Board) Option Ex 100 41.15 4,115
2010-03-23 Nutter Brad (Chairman of the Board) Sale 30,700 57.00 1,749,900
2010-03-23 Nutter Brad (Chairman of the Board) Option Ex 30,700 41.15 1,263,305
2010-03-22 Nutter Brad (Chairman of the Board) Sale 142,328 57.00 8,112,696
2010-03-22 Nutter Brad (Chairman of the Board) Option Ex 142,328 41.15 5,856,797
2010-02-18 Best Lawrence C (Director) Sale 50,000 53.42 2,670,850
2010-02-17 Best Lawrence C (Director) Sale 25,000 53.63 1,340,800
2010-02-16 Best Lawrence C (Director) Sale 25,000 53.51 1,337,675
2010-02-10 Allen Peter M (Chief Marketing Officer) Sale 2,200 52.56 115,632
2010-02-10 Allen Peter M (Chief Marketing Officer) Option Ex 2,200 21.46 47,212
2010-02-01 Best Lawrence C (Director) Sale 100,000 53.49 5,349,325
2009-10-30 White Jonathan (VP Research and Development) Buy 480 44.13 21,183
2009-10-30 Lindop Christopher J (CFO & Vice President of) Buy 166 44.13 7,325
2009-10-30 Allen Peter M (Chief Marketing Officer) Buy 131 44.13 5,781
2009-10-30 Lopez Alicia R (VP, Corporate Affairs) Buy 87 44.13 3,839
2009-10-30 Hanlon Susan M (VP Finance) Buy 155 44.13 6,840
2009-10-27 Concannon Brian (President & CEO) Sale 117 53.40 6,247
2009-10-26 Lindop Christopher J (CFO & Vice President of) Sale 107 54.52 5,833
2009-10-26 Allen Peter M (Chief Marketing Officer) Sale 92 54.52 5,015
2009-10-26 Forish Joseph J (VP, Human Resources) Sale 60 54.52 3,271
2009-10-26 Lopez Alicia R (VP, Corporate Affairs) Sale 71 54.52 3,870
2009-10-26 Hanlon Susan M (VP Finance) Sale 72 54.52 3,925
2009-10-23 Allen Peter M (Chief Marketing Officer) Sale 77 54.24 4,176
2009-10-23 Concannon Brian (President & CEO) Sale 143 54.24 7,756
2009-10-23 Forish Joseph J (VP, Human Resources) Sale 60 54.24 3,254
2009-10-23 Lopez Alicia R (VP, Corporate Affairs) Sale 72 54.24 3,905
2009-10-23 Hanlon Susan M (VP Finance) Sale 73 54.24 3,959
2009-10-09 Allen Peter M (Chief Marketing Officer) Sale 1,870 55.66 104,087
2009-10-09 Allen Peter M (Chief Marketing Officer) Option Ex 1,870 21.46 40,130
2009-09-18 Gelbman Ronald G (Director) Sale 6,000 55.78 334,698
2009-09-18 Gelbman Ronald G (Director) Option Ex 6,000 27.34 164,064
2009-05-04 Concannon Brian (President & CEO) Sale 799 53.70 42,906
2009-05-01 Lindop Christopher J (CFO & Vice President of) Buy 277 43.89 12,156
2009-05-01 Allen Peter M (President, Donor Division &) Buy 308 43.89 13,516
2009-05-01 Concannon Brian (President & CEO) Buy 424 43.89 18,607
2009-05-01 Forish Joseph J (VP, Human Resources) Buy 424 43.89 18,607
2009-05-01 Lopez Alicia R (VP, Corporate Affairs) Buy 347 43.89 15,228
2009-05-01 Ebbeling Robert B (Vice President, Operations) Buy 424 43.89 18,607
2009-05-01 Hanlon Susan M (VP Finance) Buy 152 43.89 6,670
2009-03-18 Merriman Ronald (Director) Buy 3,000 55.63 166,878
2009-03-04 White Jonathan (VP Research and Development) Buy 1,500 53.49 80,238
2009-03-02 Lopez Alicia R (VP, Corporate Affairs) Sale 9,750 51.93 506,317
2009-03-02 Lopez Alicia R (VP, Corporate Affairs) Option Ex 9,750 15.64 152,490
2009-02-17 Nutter Brad (President & CEO) Sale 100,000 59.85 5,984,900
2009-02-17 Nutter Brad (President & CEO) Option Ex 100,000 26.11 2,610,500
2009-02-04 Merriman Ronald (Director) Sale 13,000 62.85 817,050
2009-02-04 Merriman Ronald (Director) Option Ex 13,000 41.15 534,950
2009-02-02 Hanlon Susan M (VP Finance) Sale 3,000 63.00 189,000
2009-02-02 Hanlon Susan M (VP Finance) Option Ex 3,000 30.39 91,155
2009-01-26 Lopez Alicia R (VP, Corporate Affairs) Sale 2,477 60.00 148,620
2009-01-02 Lopez Alicia R (VP, Corporate Affairs) Sale 25,000 55.93 1,398,300
2009-01-02 Lopez Alicia R (VP, Corporate Affairs) Option Ex 25,000 18.94 473,425
2008-12-08 Foote Susan Bartlett (Director) Sale 20,000 58.00 1,160,000
2008-12-08 Foote Susan Bartlett (Director) Option Ex 20,000 29.89 597,900
2008-11-05 Granadillo Pedro P (Director) Buy 3,500 57.95 202,828
2008-10-31 Lindop Christopher J (CFO & Vice President of) Buy 213 45.44 9,678
2008-10-31 Lopez Alicia R (VP, General Counsel) Buy 147 45.44 6,679
2008-10-31 Hanlon Susan M (VP Finance) Buy 145 45.44 6,588
2008-10-30 Forish Joseph J (VP, Human Resources) Sale 55 55.35 3,044
2008-10-28 Concannon Brian (Chief Operating Officer) Sale 109 53.50 5,831
2008-10-28 Lopez Alicia R (VP, General Counsel) Sale 68 53.50 3,638
2008-10-28 Hanlon Susan M (VP Finance) Sale 68 53.50 3,638
2008-10-27 Lindop Christopher J (CFO & Vice President of) Sale 107 50.08 5,358
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of HAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Haemonetics Corp (symbol HAE, CIK number 313143) see the Securities and Exchange Commission (SEC) website.